Dr. Varikasuvu Seshadri Reddy
My Social Links

Dr. Varikasuvu Seshadri Reddy

Assistant Professor
Maheshwara Medical College, India

Highest Degree
Ph.D. in Medical Biochemistry from Sri Venkateswara Institue of Medical Scineces, India

Share this Profile

Biography

Dr. Varikasuvu Seshadri Reddy is currently working as Faculty member of BPS Government Medical College, India. He has completed his Ph.D. in Medical Biochemistry from Sri Venkateswara Institute of Medical Sciences, India. He is member of Society of Biological Chemists (SBC), Association of Clinical Biochemists of India (ACBI), and World Association of Science, and Engineering & Technology (WASET). He is member of editor board and referee for number of journals. He has completed 4 research projects. His area of research interest focuses on Oxidative Stress, Antioxidant Defense, Cardiovascular Risk, and Biomarkers & Disease Biochemistry. He has 31 publications in journals as author/co-author.

Area of Interest:

Biomedical Sciences
100%
Medical Biochemistry
62%
Radiation Biology
90%
Antioxidant Defense
75%
Oxidative Stress
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
40
Abstracts
0

Selected Publications

  1. Reddy, V.S., S. Bukke and M. Munikumar, 2018. Elevated levels of the circulatory ischemia-modified albumin in patients with polycystic ovary syndrome: A meta-analysis. Gynecol. Endocrinol., 10.1080/09513590.2018.1462318.
    CrossRef  |  Direct Link  |  
  2. Reddy, V.S., M. Manne, P. Duggina and N. Varma, 2018. A diagnostic test accuracy meta-analysis of maternal serum ischemia-modified albumin for detection of preeclampsia. J. Mater. Fetal Neonatal Med., 10.1080/14767058.2018.1427724.
    CrossRef  |  Direct Link  |  
  3. Reddy, V.S., S. Bukke, K. Mahato, V. Kumar, N.V. Reddy, M. Munikumar and B. Vodelu, 2017. A meta-analysis of the association of serum ischaemia-modified albumin levels with human hypothyroidism and hyperthyroidism. Biosci. Rep., Vol. 37. .
    Direct Link  |  
  4. Reddy, V.S., P. Duggina, M. Vedhantam, M. Manne, N. Varma and S. Nagaram, 2017. Maternal serum and fetal cord-blood ischemia-modified albumin concentrations in normal pregnancy and preeclampsia: A systematic review and meta-analysis. J. Mater. Fetal Neonatal Med., rg/10.1080/14767058.2017.1368480.
    CrossRef  |  Direct Link  |  
  5. RedReddy, V.S., S. Bukke, N. Dutt, P. Rana and A.K. Pandey, 2017. A systematic review and meta-analysis of the circulatory, erythrocellular and CSF selenium levels in Alzheimer's disease: A metal meta-analysis (AMMA study-I). J. Trace Elements Med. Biol., 42: 68-75.
    CrossRef  |  Direct Link  |  
  6. Chander, S.R., S.R. Varikasuvu, P.A. Kumar and A. Rupanagudi, 2017. Ischemia modified albumin concentrations in patients with rheumatoid arthritis. Int. J. Rheumatic Dis., 20: 2152-2153.
    CrossRef  |  Direct Link  |  
  7. Agrawal, P., S. Sethi, V.S. Reddy and S. Lamba, 2017. Serum uric acid and lipid profile in diabetic retinopathy in rural Haryana, India. Int. J. Adv. Med., 3: 309-312.
    CrossRef  |  Direct Link  |  
  8. Reddy, V.S., S. Sethi, N. Gupta, P. Agrawal and R.C. Siwach, 2016. Significance of ischemia-modified albumin as a simple measure of oxidative stress and its discriminatory ability in diabetic retinopathy: Literature Review and Meta-Analysis. Retina, 36: 1049-1057.
    CrossRef  |  Direct Link  |  
  9. Mouli, K.C., D. Pragathi, U.N. Jyothi, V.S Kumar and M.H. Naik et al., 2016. Leptin inhibitors from fungal endophytes (LIFEs): Will be novel therapeutic drugs for obesity and its associated immune mediated diseases. Med. Hypotheses, 92: 48-53.
    CrossRef  |  Direct Link  |  
  10. Reddy, V.S., P. Pasupuleti and B. Perugu, 2015. Implications of ischemia modified albumin levels in hypertension. Asian Pacific J. Trop. Dis., 5: S190-S191.
  11. Reddy, V.S., P. Agrawal, S. Sethi, N. Gupta, R. Garg, H. Madaan and V. Kumar, 2015. Associations of FPG, A1C and disease duration with protein markers of oxidative damage and antioxidative defense in type 2 diabetes and diabetic retinopathy. Eye, 29: 1585-1593.
    CrossRef  |  Direct Link  |  
  12. Reddy, V.S., K.C. Mouli and Y.M. Reddy, 2015. Does 10-dehydrogingerdione affect serum albumin and free fatty acid levels as it does on serum ischemia-modified albumin? J. Thrombosis Thrombolysis, 40: 308-309.
    CrossRef  |  Direct Link  |  
  13. Reddy, V.S., B. Perugu and M.K. Garg, 2015. Ischemia-modified albumin must be evaluated as an oxidative stress marker together with albumin and bilirubin in individuals with acute appendicitis. Clinics, 70: 531-532.
    CrossRef  |  Direct Link  |  
  14. Reddy, S.V., M.M. Suchitra, V. Pradeep, S. Alok, V. Suresh, A.R. Bitla and P.S. Rao, 2015. Ischemia-modified albumin levels in overt and subclinical hypothyroidism. J. Endocrinol. Invest., 38: 885-890.
    CrossRef  |  Direct Link  |  
  15. Duggina, P., C.M. Kalla, S.R. Varikasuvu, S. Bukke and V. Tartte, 2015. Protective effect of centella triterpene saponins against cyclophosphamide-induced immune and hepatic system dysfunction in rats: Its possible mechanisms of action. J. Physiol. Biochem., 71: 435-454.
    CrossRef  |  Direct Link  |  
  16. Reddy, V.S., V. Hemadri, P. Pasupuleti and B. Perugu, 2014. Cobalt-Albumin Binding (CAB) assay: An advantageous and flaw free testing of albumin-cobalt binding. J. Pharm. Biomed. Anal., 99: 79-82.
    PubMed  |  
  17. Reddy, V.S., P.V.L.N. Srinivasa Rao, M.M. Suchitra and R. Garg, 2014. Serum ischaemic-modified albumin levels might not be a marker of oxidative stress in patients with hypothyroidism. Endocrine, 46: 169-170.
  18. Reddy, V.S., P. Pasupuleti, R. Garg, H. Madaan and P. Agrawal, 2014. Ischemia modified albumin and nitric oxide in hyperthyroidism. J. Invest. Biochem., 1: 37-38.
    Direct Link  |  
  19. Reddy, V.S., P. Pasupuleti, H. Madaan, V. Kumar and A. Bharti, 2014. Ischemia modified albumin and the effect of bosentan in acute mesenteric ischemia. Nobel Med., 10: 100-101.
  20. Agrawal, P., V.S. Reddy, H. Madaan, S.K. Patra and R. Garg, 2014. Urban rural differences in atherogenic dyslipidemia (URDAD study): A retrospective report on diabetic and non-diabetic subjects of North India. J. Health Popul. Nutr., 32: 494-502.
    Direct Link  |  
  21. Vaksh, S., M. Pandey, U.S. Zingade and V.S. Reddy, 2013. The effect of vitamin-C therapy on hyperglycemia, hyperlipidemia and non high density lipoprotein level in type 2 diabetes. Int. J. LifeSci. Bt. Pharm. Res., 2: 290-295.
  22. Tejovathi, B., M.M. Suchitra, V. Suresh, V.S. Reddy, A. Sachan, P.V. Rao and A.R. Bitla, 2013. Association of lipid peroxidation with endothelial dysfunction in patients with overt hypothyroidism. Exp. Clin. Endocrinol. Diabetes, 121: 306-309.
  23. Suchitra, M.M., V.S. Reddy, K. Deepthi, A. Sachan and P.V.L.N. Srinivasa Rao, 2013. An association of hyperglycemia with plasma malondialdehyde and atherogenic lipid risk factors in newly diagnosed type2 diabetic patients. J. Res. Med. Sci., 18: 89-93.
  24. Shivakrishna, G., V.S. Reddy, A.R. Bitla, A. Sachan and V. Suresh et al., 2013. Evaluation of dyslipidemia, lipid ratios and atherogenic index as cardiovascular risk factors in overt and subclinical hypothyroid patients. Nat. J. Lab. Med., 2: 11-15.
  25. Reddy, V.S., S. Gouroju, M.M. Suchitra, V. Suresh, A. Sachan, P.V. Srinivasa Rao and A.R. Bitla, 2013. Antioxidant defense in overt and subclinical hypothyroidism. Horm. Metab. Res., 45: 754-758.
  26. Reddy, V.S., P. Pullaiah, M. Himanshu, A. Poonam and G. Renu, 2013. Confounding factors: Mind it to avoid. J. Clin. Biomed. Sci., 3: 150-151.
  27. Reddy, V.S., P. Pasupuleti, P.V.L.N.S. Rao, R. Garg and A. Haribabu, 2013. Ischemia-modified albumin in patients with hyperthyroidism and hypothyroidism. Eur. J. Int. Med., 25: e42-e43.
  28. Haribabu, A., V.S. Reddy, C. Pallavi, A.R. Bitla and A. Sachan et al., 2013. Evaluation of protein oxidation and its association with lipid peroxidation and thyrotropin levels in overt and subclinical hypothyroidism. Endocrine, 44: 152-157.
  29. Balaji, R., P.B. Dolia, V.K. Arumalla and V.S. Reddy, 2013. Renal function markers and thyroid hormone status in undialyzed chronic kidney disease. Al Ameen J. Med. Sci., 6: 70-74.
  30. Suchitra, M.M., V.L. Ashalatha, E. Sailaja, A.M. Rao and V.S. Reddy et al., 2011. The effect of L-Carnitine supplementation on lipid parameters, inflammatory and nutritional markers in maintenance hemodialysis patients. Saudi J. Kidney Dis. Transpl., 22: 1155-1159.
    PubMed  |  Direct Link  |  
  31. Suchitra, M.M., M. Pallavi, A. Sachan, V.S. Reddy, A.R. Bitla and P.V.L.N. Srinivasa Rao, 2011. Lipid peroxidation measured as serum malondialdehyde and vitamin-c as oxidative-antioxidative biomarkers in type II diabetic patients. Int. J. Biomed. Adv. Res., 2: 378-388.
  32. Bitla, A.R., E.P. Reddy, K. Sambasivaiah, M.M. Suchitra, V.S. Reddy and P.V.L.N.S. Rao, 2011. Evaluation of plasma malondialdehyde as a biomarker in patients with carcinoma of stomach. Biomed. Res., 22: 63-68.
    Direct Link  |  
  33. Reddy, V.S., M.M. Suchitra, Y.M. Reddy and E.P. Reddy, 2010. Beneficial and detrimental actions of free radicals: A review. J. Global Pharma Technol., 2: 3-11.
    Direct Link  |  
  34. Reddy, P.E., S.M. Manohar, V.S. Reddy, A.R. Bitla, S. Vishnubotla and P.V.L.N.S. Rao, 2010. Ferric reducing ability of plasma and lipid peroxidation in hemodialysis patients: Intradialytic changes. Int. J. Nephrol. Urol., 2: 414-421.
    Direct Link  |  
  35. Reddy, P.E., V.S. Reddy, K.C. Mouli and P.V.L.N.S. Rao, 2010. Physiological antioxidant system and oxidative stress in stomach cancer patients with normal renal and hepatic function. Online J. Health Allied Sci., .
    Direct Link  |  
  36. Reddy, E., M.M. Suchitra, V.S. Reddy, A.R. Bitla, V.S. Kumar and P.V.L.N. Srinivasa Rao, 2009. Hemodialysis and dyslipidemia. Ind. J. Comparat. Anim. Physiol., 27: 55-59.
  37. Reddy, E, M.M. Suchitra, V.S. Reddy, A.R. Bitla and P.V.L.N.S. Rao, 2009. Dyslipidemia: End stage renal disease and hemodialysis. Internet J. Nephrol., Vol. 5. .
    Direct Link  |  
  38. Bitla, A.R., M. Pallavi, V. Vanaja, M.M. Suchitra, V.S. Reddy, E.P. Reddy and P.V.L.N.S. Rao, 2009. Acute myocardial infarction in southeast Indian population: Comparison of traditional and novel cardiovascular risk factors. Res. J. Med. Med. Sci., 4: 202-206.
    Direct Link  |  
  39. Reddy, V.S., A.R. Bitla, V.S. Kumar, E.P. Reddy, M.M. Suchitra, K.V.N. Raju and P.V.L.N.S. Rao, 2008. Effect of hemodialysis session on plasma branched chain amino acids in patients without evidence of malnutrition. The Bioscan., 3: 533-536.
  40. Rao, P.V.L.N.S., A.R. Bitla, V.S. Reddy, V.S. Kumar, M.M. Suchitra and E.P. Reddy, 2008. Effect of a dialysis session on plasma branched chain amino acids in hemodialysis patients. Indian J. Clin. Biochem., 23: S57-S58.